Select one of the following processes: dysplasia, apoptosis, or breast cancer mutations (e.g., BRCA1/BRCA2). In your discussion:
Explain how the cellular changes contribute to the clinical manifestations of the condition. Consider how these microscopic alterations translate into the patient’s signs, symptoms, and diagnostic findings.
Discuss how genetic or environmental risk factors influence disease development or progression. Include examples such as inherited mutations, carcinogen exposure, hormonal influences, or lifestyle factors.
Integrate evidence-based resources to support your explanation, emphasizing implications for screening, prevention, and early intervention in advanced nursing practice.
Sample Answer
The BRCA1 and BRCA2 genes are tumor suppressor genes responsible for repairing double-strand DNA breaks through a process called homologous recombination. When these genes undergo a deleterious mutation, the cell's ability to maintain genomic stability is compromised.
Microscopic Alterations: Without functional BRCA proteins, DNA errors go unrepaired and accumulate. This leads to genomic instability, where cells bypass normal checkpoints, avoid apoptosis (programmed cell death), and begin uncontrolled proliferation. Over time, these cells undergo "malignant transformation," forming a palpable mass.
Translation to Clinical Manifestations:
Palpable Mass: The rapid, uninhibited division of mutated cells results in a hard, fixed, or irregular lump, often in the upper outer quadrant of the breast.
Skin Changes: As the tumor grows, it can involve the Cooper’s ligaments, causing skin dimpling or nipple retraction.